Skip to main content
. 2020 Jan 21;8(1):22. doi: 10.3390/healthcare8010022

Table 2.

Demographics and nebuliser treatments of participants.

Participant
Number
Sex Predicted lung function (%) Baseline adherence (%) Nebuliser
treatment
Total Doses of Treatment Prescribed per Day
1 Female 89% 73% 2 mucolytics 3
2 Female 89% 99% 2 mucolytics 3
3 Female 73% 15% 1 mucolytic and 1 antibiotic 5
4 Male 80% 68% 2 mucolytics and 1 antibiotic 9
5 Female 96% 100% 1 mucolytic and 1 antibiotic 6
6 Female 45% 41% 1 mucolytic and 1 antibiotic 6